There is now new technology in giving people what they want: a way to stop aging. With the new advancement in cell biology involving the discovery of the rapamycin molecule, it’s now easy to hope for the remedy for not looking old. In the report from Bloomberg, researchers discovered in the early 1900s the rapamycin molecule that helps in inhibiting the cellular pathway of the body to produce the cells responsible for aging. The cell is also responsible for the growth and metabolism of the same cells that do not contribute to making your skin look young. The cell consumes the nutrients in your body when it divides itself, and so helps in making your skin look aged and deteriorate.One of the many people passionate about the growth of rapamycin is the Russian scientist Mikhail Blagosklonny who now works at the Roswell Park Cancer Institute in Buffalo to find the better cancer treatments today that tap into the power of rapamycin in lowering the growth rate of a tumor. Incidentally, the study to decrease the growth of the aging cells will also help the body fight their anti-aging properties.
About Mikhail Blagosklonny
Russian scientist Mikhail Blagosklonny earned both his degree in internal medicine and Ph.D. in experimental medicine at the First Pavlov State Medical University of St. Peterburg. His passion for cardiology, cancer treatment, and internal medicine also brought him the role of an assistant professorship of medicine at the New York Medical College, in Valhalla NY last 2002.He also took the position of being the senior scientist to discover more research subjects for cancer treatment at Ordway Research Institute until he gave up the position in 2009. The primary focus of Mikhail Blagosklonny’s research was always for cancer therapy and other methods that answer the questions involving the damage to healthy cells. However, he is also much interested in expanding his theories, and Oncology plans about the anti-aging cells to find ways of addressing aesthetic concerns.
In fact, Healing Magic reports that his plans on oncology want to incorporate his interests in Rapamycin and aging as Blagosklonny was able to hypothesize different ideas on the potential of rapamycin for making sure that the damaged cells causing aging will replenish. It is also the vision of Mikhail to use his extensive study about rapamycin to find means to extend the life of people who want more out of life.Passion for Editorial WritingBlagosklonny’s passion for research also brought him to do a lot of editorial work about aging in several journals, including medical journals like Aging, Oncotarget and Cell Cycle. Being the associate editor of Cancer Biology and Therapy also gave him the chance to expand his studies in cancer therapy and rapamycin. Mikhail’s passion for rapamycin also made him study how the cell can affect a person’s immune system, and how these can bring transplants to a different level. It was also his breakthrough study last 2014 through the Science Translational Medicine that he discovered a way to administer small doses of everolimus, a derivative of rapamycin, to elderly patients, so that they benefit from the anti-aging molecules without causing damage to their health.